ID

24263

Description

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Mots-clés

  1. 28/07/2017 28/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

28 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADO

GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911

Study administration
Description

Study administration

Subject Identifier
Description

Subject Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Visit Date
Description

Visit Date

Type de données

date

Unités de mesure
  • DD/MMM/YY
Alias
UMLS CUI [1]
C1320303
DD/MMM/YY
SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS
Description

SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS

Category A:
Description

· Asymptomatic HIV infection • Persistent generalized lymphadenopathy • Acute (primary) HIV infection with accompanying illness or history of acute HIV

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0497156
Category B: Symptomatic (non-AIDS) Conditions
Description

Category B:

Type de données

boolean

Alias
UMLS CUI [1,1]
C3888530
UMLS CUI [1,2]
C0012634
Category C: AIDS Indicator Conditions as defined by diagnostic or presumptive measures
Description

Category C:

Type de données

boolean

Alias
UMLS CUI [1,1]
C3888531
UMLS CUI [1,2]
C0012634

Similar models

GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS
Category A:
Item
Category A:
boolean
C0019693 (UMLS CUI [1])
C0497156 (UMLS CUI [2])
Category B:
Item
Category B: Symptomatic (non-AIDS) Conditions
boolean
C3888530 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Category C:
Item
Category C: AIDS Indicator Conditions as defined by diagnostic or presumptive measures
boolean
C3888531 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial